Management of bradykinin-mediated angioedema;Prise en charge en urgence de l'angiœdème à bradykinine

Annales Francaises d'Anesthesie et de Reanimation

Volumn 30, Issue 7-8, 2011, Pages 578-588

  Floccard, B ^a   Crozon, J ^a   Rimmele T ^a   Vulliez, A ^a   Coppere, B ^a   Chamouard, V ^b   Boccon Gibod, I ^c   Bouillet, L ^c   Allaouchiche, B ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c HÔPITAL MICHALLON   (France)

Author keywords

Anaesthesia; Anesth sie; Angi d me; Angioedema; C1 inhibitor concentrate; Concentr de C1 inhibiteur; Icatibant

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BLOOD CLOTTING FACTOR 12; BRADYKININ; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1S INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; TRANEXAMIC ACID;

ANESTHESIST; ANGIONEUROTIC EDEMA; BRADYKININ MEDIATED ANGIOEDEMA; CAPILLARY PERMEABILITY; CHILDBIRTH; COMPLEMENT DEFICIENCY; DENTAL CARE; EMERGENCY PHYSICIAN; EMERGENCY TREATMENT; HUMAN; INTENSIVE CARE; LARYNX EDEMA; PERIOPERATIVE PERIOD; PREGNANT WOMAN; SHORT SURVEY; SURGICAL INJURY;

ALGORITHMS; ANGIOEDEMA; BRADYKININ; EMERGENCY TREATMENT; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 79960619659     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2011.01.011     Document Type: Short Survey

References (55)

1. Zuraw B.L. Clinical practice. Hereditary angioedema. N Engl J Med 2008, 359:1027-1036.
2. Jensen N.F., Weiler J.M. C1 esterase inhibitor deficiency, airway compromise, and anesthesia. Anesth Analg 1998, 87:480-488.
3. Levy J.H., Freiberger D.J., Roback J. Hereditary angioedema: current and emerging treatment options. Anesth Analg 2010, 110:1271-1280.
4. Bowen T., Cicardi M., Farkas H., Bork K., Kreuz W., Zingale L., et al. Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. J Allergy Clin Immunol 2004, 114:629-637.
5. Bowen T., Cicardi M., Bork K., Zuraw B., Frank M., Ritchie B., et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008, 100(1 Suppl. 2):S30-S40.
6. Bowen T., Cicardi M., Farkas H., Bork K., Longhurst H.J., Zuraw B., et al. 2010 International Consensus Algorithm for the Diagnosis, Therapy and Management of Hereditary Angioedema. Allergy Asthma Clin Immunol 2010, 6:24.
7. Gompels M.M., Lock R.J., Abinun M., Bethune C.A., Davies G., Grattan C., et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005, 139:379-394.
8. Floccard B., Crozon J., Coppere B., Bouillet L., Allaouchiche B. Angio-œdème à bradykinine. Maladies rares en réanimation. Edited by Springer 2010, 36-274. Leone M, Paris.
9. Farkas H., Varga L., Szeplaki G., Visy B., Harmat G., Bowen T. Management of hereditary angioedema in pediatric patients. Pediatrics 2007, 120:e713-e722.
10. Han E.D., MacFarlane R.C., Mulligan A.N., Scafidi J., Davis A.E. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 2002, 109:1057-1063.
11. Agostoni A., Aygoren-Pursun E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clinical Immunol 2004, 114(3 Suppl.):S51-S131.
12. Agostoni A., Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine 1992, 71:206-215.
13. Bork K., Siedlecki K., Bosch S., Schopf R.E., Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clinic Proc 2000, 75:349-354.
14. Bork K., Hardt J., Schicketanz K.H., Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 2003, 163:1229-1235.
15. Bork K., Staubach P., Eckardt A.J., Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 2006, 101:619-627.
16. Longhurst H.J., Farkas H., Craig T., Aygoren-Pursun E., Bethune C., Bjorkander J., et al. HAE international home therapy consensus document. Allergy Asthma Clin Immunol 2010, 6:22.
17. Bork K., Barnstedt S.E. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc 2003, 134:1088-1094.
18. Kaplan A.P., Greaves M.W. Angioedema. J Am Acad Dermatol 2005, 53:373-388.
19. Bas M., Adams V., Suvorava T., Niehues T., Hoffmann T.K., Kojda G. Nonallergic angioedema: role of bradykinin. Allergy 2007, 62:842-856.
20. Bouillet L., Longhurst H., Boccon-Gibod I., Bork K., Bucher C., Bygum A., et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 2008, 199:e481-e484.
21. Bork K., Wulff K., Hardt J., Witzke G., Staubach P. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J Allergy Clin Immunol 2009, 124:129-134.
22. Cicardi M., Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol 2010, 6:14.
23. Cugno M., Nussberger J., Cicardi M., Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003, 3:311-317.
24. Davis A.E. The pathophysiology of hereditary angioedema. Clin Immunol 2005, 114:3-9.
25. Bossi F., Fischetti F., Regoli D., Durigutto P., Frossi B., Gobeil F., et al. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol 2009, 124:1303-1310. [e1304].
26. Cugno M., Castelli R., Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmunity Rev 2008, 8:156-159.
27. Bork K., Frank J., Grundt B., Schlattmann P., Nussberger J., Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 2007, 119:1497-1503.
28. Cicardi M., Banerji A., Bracho F., Malbran A., Rosenkranz B., Riedl M., et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010, 363:532-541.
29. Bouillet L., Boccon-Gibod I., Ponard D., Drouet C., Cesbron J.Y., Dumestre-Perard C., et al. Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks. Ann Allergy Asthma Immunol 2009, 103:448.
30. De Serres J., Groner A., Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. Transfus Apher Sci 2003, 29:247-254.
31. Longhurst H.J. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?. Int J Clin Pract 2005, 59:594-599.
32. Farkas H., Jakab L., Temesszentandrasi G., Visy B., Harmat G., Fust G., et al. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol 2007, 120:941-947.
33. Cicardi M., Zingale L., Zanichelli A., Deliliers D.L. Established and new treatments for hereditary angioedema: an update. Mol Immunol 2007, 44:3858-3861.
34. Craig T.J., Levy R.J., Wasserman R.L., Bewtra A.K., Hurewitz D., Obtulowicz K., et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009, 124:801-808.
35. Krassilnikova S., Craig E.T., Craig T.J. Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2). Expert Rev Clin Immunol 2010, 6:327-334.
36. Levi M., Choi G., Picavet C., Hack C.E. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 2006, 117:904-908.
37. Prematta M., Gibbs J.G., Pratt E.L., Stoughton T.R., Craig T.J. Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 2007, 98:383-388.
38. Zuraw B.L. Hereditary angiodema: a current state-of-the-art review. IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new?. Ann Allergy Asthma Immunol 2008, 100(1 Suppl. 2):S13-S18.
39. Craig T.J., Wasserman R.L., Levy R.J., Bewtra A.K., Schneider L., Packer F., et al. Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema. J Clin Immunol 2010, 30:823-829.
40. Trachsel D., Hammer J. A vote for inhaled adrenaline in the treatment of severe upper airway obstruction caused by piercing of the tongue in hereditary angioedema. Intensive Care Med 1999, 25:1335-1336.
41. Ritchie B.C. Protease inhibitors in the treatment of hereditary angioedema. Transfus Apher Sci 2003, 29:259-267.
42. Morgan B.P. Hereditary angioedema-therapies old and new. N Engl J Med 2010, 363:581-583.
43. Visy B., Fust G., Bygum A., Bork K., Longhurst H., Bucher C., et al. Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. Helicobacter 2007, 12:251-257.
44. Banerji A., Sloane D.E., Sheffer A.L. Hereditary angioedema: a current state-of-the-art review. V: attenuated androgens for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 2008, 100(1 Suppl. 2):S19-S22.
45. Drouet C., Desormeaux A., Robillard J., Ponard D., Bouillet L., Martin L., et al. Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. J Allergy Clin Immunol 2008, 121:429-433.
46. Bouillet L. Hereditary angioedema in women. Allergy Asthma Clin Immunol 2010, 6:17.
47. Minville V., Saada J., Cartron G., Legac Y.T., Desprats R. Caesarean section in a parturient with C1 esterase inhibitor deficiency (angioneurotic oedema). Ann Fr Anesth Reanim 2006, 25:315-316.
48. Libert N., Scherier S., Dubost C., Franck L., Rouquette I., Tortosa J.C., et al. Anaesthesic management of vaginal delivery in a parturient with C1 esterase deficiency. Ann Fr Anesth Reanim 2009, 28:375-380.
49. Koeberle P., Pequenot-Jeannin C., Douge C., Barale F. Angioneurotic edema and anesthesia: preparation and perioperative monitoring. Ann Fr Anesth Reanim 1994, 13:417-420.
50. Frank M.M. Hereditary angiodema: a current state-of-the-art review. VI: novel therapies for hereditary angioedema. Ann Allergy Asthma Immunol 2008, 100(1 Suppl. 2):S23-S29.
51. Bernstein J.A. Hereditary angioedema: a current state-of-the-art review. VIII: current status of emerging therapies. Ann Allergy Asthma Immunol 2008, 100(1 Suppl. 2):S41-S46.
52. Longhurst H. Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia. Curr Opin Investig Drugs 2008, 9:310-323.
53. Zuraw B.L., Busse P.J., White M., Jacobs J., Lumry W., Baker J., et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 2010, 363:513-522.
54. Cicardi M., Levy R.J., McNeil D.L., Li H.H., Sheffer A.L., Campion M., et al. Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med 2010, 363:523-531.
55. Kanji S., Chant C. Allergic and hypersensitivity reactions in the intensive care unit. Crit Care Med 2010, 38(6 Suppl.):S162-S168.